Associations Between Income and Survival in Cholangiocarcinoma: A Comprehensive Subtype-based Analysis

Overview

Journal Ann Hepatobiliary Pancreat Surg

Date 2024 Feb 15

PMID 38356257

Authors

Calvin X Geng

Anuragh R Gudur

Jagannath Kadiyala

Daniel S Strand

Vanessa M Shami

Andrew Y Wang

Alexander Podboy

Tri M Le

Matthew Reilley

Victor Zaydfudim

Ross C D Buerlein

Affiliations

Soon will be listed here.

Abstract

Backgrounds/aims: Socioeconomic determinants of health are incompletely characterized in cholangiocarcinoma (CCA). We assessed how socioeconomic status influences initial treatment decisions and survival outcomes in patients with CCA, additionally performing multiple sub-analyses based on anatomic location of the primary tumor.

Methods: Observational study using the 2018 submission of the Surveillance, Epidemiology, and End Results (SEER)-18 Database. In total, 5,476 patients from 2004-2015 with a CCA were separated based on median household income (MHI) into low income (< 25th percentile of MHI) and high income (> 25th percentile of MHI) groups. Seventy-three percent of patients had complete follow up data, and were included in survival analyses. Survival and treatment outcomes were calculated using R-studio.

Results: When all cases of CCA were included, the high-income group was more likely than the low-income to receive surgery, chemotherapy, and local tumor destruction modalities. Initial treatment modality based on income differed significantly between tumor locations. Patients of lower income had higher overall and cancer-specific mortality at 2 and 5 years. Non-cancer mortality was similar between the groups. Survival differences identified in the overall cohort were maintained in the intrahepatic CCA subgroup. No differences between income groups were noted in cancer-specific or overall mortality for perihilar tumors, with variable differences in the distal cohort.

Conclusions: Lower income was associated with higher rates of cancer-specific mortality and lower rates of surgical resection in CCA. There were significant differences in treatment selection and outcomes between intrahepatic, perihilar, and distal tumors. Population-based strategies aimed at identifying possible etiologies for these disparities are paramount to improving patient outcomes.

References

Lee R, Liu Y, Gamboa A, Zaidi M, Kooby D, Shah M . Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: What is driving disparities in receipt of treatment?. J Surg Oncol. 2019; 120(4):611-623. PMC: 6752195. DOI: 10.1002/jso.25632. View

Thomson C, Hole D, Twelves C, Brewster D, Black R . Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health. 2001; 55(5):308-15. PMC: 1731899. DOI: 10.1136/jech.55.5.308. View

Zhu M, Li Y . The correlations between socioeconomic status and intrahepatic cholangiocarcinoma in the United States: a population-based study. Transl Cancer Res. 2022; 9(8):4931-4942. PMC: 8798916. DOI: 10.21037/tcr-20-2506. View

Uppal D, Wang A . Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma. World J Gastrointest Endosc. 2015; 7(7):675-87. PMC: 4482827. DOI: 10.4253/wjge.v7.i7.675. View

Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J . Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health. 2003; 57(4):301-9. PMC: 1732424. DOI: 10.1136/jech.57.4.301. View

Geng C, Gudur A, Radlinski M, Buerlein R, Strand D, Sauer B . Socioeconomic Disparities Affect Outcomes in Early-Stage Esophageal Adenocarcinoma: A SEER Analysis. Clin Gastroenterol Hepatol. 2023; 21(11):2797-2806.e6. DOI: 10.1016/j.cgh.2023.02.011. View

Zullig L, Jackson G, Provenzale D, Griffin J, Phelan S, Van Ryn M . Transportation: a vehicle or roadblock to cancer care for VA patients with colorectal cancer?. Clin Colorectal Cancer. 2011; 11(1):60-5. PMC: 3274660. DOI: 10.1016/j.clcc.2011.05.001. View

Woods L, Rachet B, Coleman M . Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2005; 17(1):5-19. DOI: 10.1093/annonc/mdj007. View

Singh G, Jemal A . Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950-2014: Over Six Decades of Changing Patterns and Widening Inequalities. J Environ Public Health. 2017; 2017:2819372. PMC: 5376950. DOI: 10.1155/2017/2819372. View

10.

Patel N, Benipal B . Incidence of Cholangiocarcinoma in the USA from 2001 to 2015: A US Cancer Statistics Analysis of 50 States. Cureus. 2019; 11(1):e3962. PMC: 6436669. DOI: 10.7759/cureus.3962. View

11.

Walter D, Ferstl P, Waidmann O, Trojan J, Hartmann S, Schnitzbauer A . Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification. Liver Int. 2018; 39(2):316-323. DOI: 10.1111/liv.13954. View

12.

Cillo U, Fondevila C, Donadon M, Gringeri E, Mocchegiani F, Schlitt H . Surgery for cholangiocarcinoma. Liver Int. 2019; 39 Suppl 1:143-155. PMC: 6563077. DOI: 10.1111/liv.14089. View

13.

Welzel T, McGlynn K, Hsing A, OBrien T, Pfeiffer R . Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006; 98(12):873-5. DOI: 10.1093/jnci/djj234. View

14.

Khan S, Tavolari S, Brandi G . Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019; 39 Suppl 1:19-31. DOI: 10.1111/liv.14095. View

15.

Ilyas S, Gores G . Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013; 145(6):1215-29. PMC: 3862291. DOI: 10.1053/j.gastro.2013.10.013. View

16.

Gad M, Saad A, Faisaluddin M, Gaman M, Ruhban I, Jazieh K . Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends. Clin Res Hepatol Gastroenterol. 2020; 44(6):885-893. DOI: 10.1016/j.clinre.2020.03.024. View

17.

Brindley P, Bachini M, Ilyas S, Khan S, Loukas A, Sirica A . Cholangiocarcinoma. Nat Rev Dis Primers. 2021; 7(1):65. PMC: 9246479. DOI: 10.1038/s41572-021-00300-2. View

18.

Khan S, Emadossadaty S, G Ladep N, Thomas H, Elliott P, Taylor-Robinson S . Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?. J Hepatol. 2011; 56(4):848-54. DOI: 10.1016/j.jhep.2011.11.015. View